Company news
Dermata Therapeutics, Inc. news in 2024
Dermata Therapeutics, Inc.'s news releases, calls and decks from 2024, newest first.
Dermata Receives Approval from FDA for the Proprietary Name Xyngari
December 17, 2024
Dermata Receives Approval from FDA for the Proprietary Name Xyngari(TM)
December 15, 2024
Dermata Receives Notice of Allowance for New U.S. Patent for DMT310 for the Treatment of Acne
December 9, 2024
Dermata Completes Enrollment in First Pivotal DMT310 Phase 3 STAR-1 Clinical Trial for Acne
December 2, 2024
Dermata Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results
November 12, 2024
Dermata Therapeutics to Present at the Life Sciences Investor Forum on Thursday, November 14, 2024
November 10, 2024
Dermata Therapeutics to Participate in the 2024 Maxim Healthcare Virtual Summit on Tuesday, October 15, 2024
October 7, 2024
Dermata Therapeutics Announces Closing of $3.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules
September 16, 2024
Dermata Therapeutics Announces $3.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules
September 15, 2024
Dermata Therapeutics Announces Participation at the H.C. Wainwright 26th Annual Global Investment Conference September 9-11, 2024
September 4, 2024
Dermata Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results
August 6, 2024
Dermata Announces Achievement of 50% Enrollment in Pivotal DMT310 Phase 3 STAR-1 Clinical Trial for Acne
July 16, 2024
Dermata Therapeutics Announces Exercise of Warrants for $2.66 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules
May 16, 2024
Dermata Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
May 14, 2024
Dermata to Present at the Emerging Growth Conference on April 3, 2024
March 26, 2024
Dermata to Present at the Emerging Growth Conference on February 7, 2024
January 31, 2024
Dermata Expands Global Intellectual Patent Portfolio with Issuance of Japanese Patent for DMT410 for the Treatment of Hyperhidrosis
January 3, 2024